Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADS-01 multiple-dose exploratory study in refractory skin ulcers
jRCT2033260542Not yet recruiting
- Sponsor
- AdipoSeeds
- Start
- Nov 2026
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Open-label, single-arm trial of ADS-01 in Cutaneous ulcer, arterial ulcer and stasis ulcer, sponsored by AdipoSeeds. Primary endpoint: Incidence rate of adverse events. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
ADS-01
03
Conditions
Cutaneous ulcerarterial ulcerstasis ulcer
Beyond the preview
Go deeper on jRCT2033260542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2033260542.